Tumor-induced osteomalacia (TIO) is an ultrarare paraneoplastic syndrome due to
overproduction of fibroblast growth factor 23 (FGF23), with profound effects on patient …

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by tumoral
production of fibroblast growth factor 23 (FGF23). The hallmark biochemical features include …

Perhaps the rarest cause of osteomalacia is that caused by a neoplasm, so-called “tumor-
induced osteomalacia”(TIO). Although very rare cases of TIO have been associated with …

Background Tumor-induced osteomalacia is a paraneoplastic syndrome resulting in renal
phosphate wasting and decreased bone mineralization. Phosphaturic mesenchymal tumors …

Background Tumor-induced osteomalacia (TIO) is a rare syndrome typically caused by
mesenchymal tumors. It has been shown that complete tumor resection may be curative …

Phosphaturic mesenchymal tumors of the mixed connective tissue type (PMT) are very rare
tumors of bone and soft tissues. Most patients with PMT have long-standing osteomalacia …

Background Tumor‐induced osteomalacia (TIO) belongs to a rare disease of the
paraneoplastic syndrome. Phosphate uric mesenchymal tumor (PMT) is the most common …

Tumor‑induced osteomalacia (TIO) is a rare acquired form of hypophosphatemia commonly
associated with phosphaturic mesenchymal tumors (PMTs) located in the bone or soft tissue …

Phosphaturic mesenchymal tumor (PMT) is a rare neoplasm that secretes fibroblast growth
factor-23 (FGF-23) and causes oncogenic osteomalacia. It occurs in adults with equal …

Phosphaturic mesenchymal tumor, mixed connective tissue variant (PMT-MCT) causes
tumor-induced osteomalacia (TIO). Most cases follow a benign clinical course, with rare …